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Blind subterranean mole rats retain a degenerated, subcutaneous,
visually blind but functionally circadian eye involved in photope-
riodic perception. Here we describe the cloning, sequence, and
expression of the circadian Clock and MOP3 cDNAs of the Spalax
ehrenbergi superspecies in Israel. Both genes are relatively con-
served, although characterized by a significant number of amino
acid substitutions. The glutamine-rich area of Clock, which is
assumed to function in circadian rhythmicity, is expanded in Spalax
compared with that of humans and mice, and is different in amino
acid composition from that of rats. We also show that MOP3 is a
bona fide partner of Spalax Clock and that the Spalax ClockMOP3
dimer is less potent than its human counterpart in driving tran-
scription. We suggest that this reduction in transcriptional activity
may be attributed to the Spalax Clock glutamine-rich domain,
which is unique in its amino acid composition compared with other
studied mammalian species. Understanding ClockMOP3 function
could highlight circadian mechanisms in blind mammals and their
unique pattern as a result of adapting to life underground.
Biological Clocks Underground
The behavior of all eukaryotic organisms is characterized bya 24-h cycle of rest and activity, as a fundamental adaptation
to the solar cycle of light and darkness (1–4). In mammals, the
pacemaker of this circadian rhythm is localized in the central
nervous system (5) and it is entrained by light signals in the eye.
An intriguing question is how a subterranean, naturally blind
mammal with a subcutaneous degenerated eye maintains its
circadian system, and whether its examination can illuminate
circadian rhythmicity of sighted mammals above ground.
The underground adaptive ecogeographical radiation of the
Spalax ehrenbergi superspecies in Israel involves four sibling
species: Spalax galili, Spalax golani, Spalax carmeli, and Spalax
judaei, with diploid chromosome numbers 2n  52, 54, 58, and
60, respectively (6), displaying progressive stages of final eco-
logical speciation (7, 8). Their adaptive radiation in Israel, from
early Pleistocene to Recent times, is closely associated with
increasing aridity stress, hence, with distinct climatic diversity. S.
galili, radiated in the cool-humid northern upper Galilee Moun-
tains; S. golani, in the cool-semidry northeastern Golan Heights;
S. carmeli, in warm-humid central Israel; and S. judaei, in
warm-dry southern Samaria, Judea, and the northern Negev
mountains and plains.
Spalax represents an extreme example of natural eye and brain
reorganization in mammals (8, 9). The animal is completely blind
(10), yet the retina of the atrophied subcutaneous eye functions
in photoentrainment of locomotor activity and thermoregula-
tory rhythms (11–13). Ocular regression of thalamic sight struc-
tures conceals adaptive progression of the photoperiodic system
(14, 15). Retinal rhodopsin (16) and coneopsin participate in
photoentrainment (17, 18). Per-homologous ACNGGN se-
quence comprising poly(Thr-Gly) shows hypothalamic circadian
oscillation (19). Thus, Spalax displays behavioral circadian
rhythm adapted to life underground.
Activity patterns were tested in the four sibling species of the S.
ehrenbergi superspecies (20). Activity patterns were found to be
polyphasic and polymorphic (19, 20), with a remarkable intra- and
interspecies diversity in circadian patterns (refs. 21 and 22—no
species is identified in the latter study) coupled with seasonal shifts.§
This complex pattern is unique in mammals analyzed to date. These
patterns may display an adaptive strategy of a subterranean mam-
mal, safeguarded from above-ground predation.
Molecular Genetic Basis of Circadian Rhythms
In recent years, tremendous progress has been achieved in revealing
the molecular-genetic basis of circadian activity in different organ-
isms across phylogeny, including cyanobacteria, plants, fungi, in-
sects, and mammals (1, 23). All show homologous circadian mol-
ecules, both structurally and functionally (23). The circadian genes
identified in mammals are Clock, MOP3, Per1, Per2, Per3, Tim, Cry1,
and Cry2 (23), all interacting in circadian rhythmicity. In Drosophila,
the sex-linked period (Per) gene affects rhythmicity in circadian
(24-h), ultradian (24-h), and infradian (24-h) time domains
(24). Work in Drosophila and mice suggested a mechanism in which
expression of Per genes is driven by a CLOCKMOP3 heterodimer,
which, through their basic helix–loop–helix (bHLH) motif and the
PAS domains, binds to the E-box present in the Per promoter,
thereby activating Per transcription. PERTIM and PERCRY
complexes probably block the activation of Per transcription by
interfering with the activity of ClockMOP3 (25). Indeed, it was
recently proven (26) that the loss of PAS protein MOP3 in mice
results in immediate and complete loss of circadian rhythmicity.
Recent studies (27) more specifically clarify the detailed mecha-
nism of the regulation of the circadian rhythm. Studying mutant
Clock, Per2, and Cry of mice, Shearman et al. (27) showed that Per2
has a dominant role in the positive regulation of the MOP3, whereas
the Crys are the negative regulators of the Per and Cry cycles. Clock
mutants appear to positively alter the regulation of MOP3 gene
expression in the suprachiasmatic nucleus (SCN), but not the
regulation of Clock itself. As the oscillations of the Pers and Crys
RNA are down-regulated in the Clock mutant mice, the effect of
Clock on MOP3 levels is probably indirect and may occur through
the Pers andor the Crys proteins; the reduced levels of one or
more of these genes may cause the reduced levels of MOP3 in the
Clock mutant mice through loss of the positive control of MOP3
transcription.
The underlying genetic basis of circadian rhythms in the blind,
subterranean mole rats may be different from that of strictly
diurnal or nocturnal and sighted mammals, such as humans and
mice, which presumably lack multiphasic, polymorphic, and
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seasonal biological circadian patterns. The coupled ecological
and phylogenetic uniqueness of Spalax makes it an intriguing
model organism for assessing the molecular-genetic machinery
of the biological clock.
Our objectives in this study were to compare and contrast the
structure and the expression of the Clock gene in the blind
subterranean mole rat with those of other mammals, and suggest
experiments for its potential effects on the unique circadian
rhythmicity of these species. We show differences in Clock
structure and expression between mole rats, rats, mice, and
humans. We also demonstrate differences among three mole rat
species whose significance may derive from the ecological dif-
ferences of the species—a testable hypothesis.
Materials and Methods
Animals. Animals used for the cloning of the mole rat Clock
belong to three species of the S. ehrenbergi superspecies in Israel
(6–8). The species name is followed by the diploid chromosome
number, population name, and the geographic region: S. galili,
2n  52, Kerem Ben Zimra, Upper Galilee; S. carmeli, 2n  58,
Muhraka, Mt. Carmel; S. judaei, 2n  60, Anza, Samaria. The
S. galili was also used for the cloning of MOP3. All of the animals
used in these experiments were captured in the field and kept in
our animal facility for at least 3 months before use. Animals were
housed in individual cages, each species in a separate room. They
were kept under controlled conditions of 22–24°C with seasonal
lightdark hours and fed with carrots and apples. Animals used
in this study were adults and of similar weight (100–150 g).
Cloning. By reverse transcriptase (RT)-PCR (28), we cloned the
complete ORF of Clock from three individuals each belonging to
a different species as described above. The oligonucleotides used
for the RT-PCR cloning were designed according to the published
sequence of human Clock (GenBank accession no. AF011568) and
that of the mouse (GenBank accession no. AF000998). These were
a 5 sense oligonucleotide 5-ACAAGACGAAAAC(GA)TA-
(GA)T(AG)TGTTATG (the 3 ATG is the initiation codon), and
a 3 antisense oligonucleotide 5-AGAGAGGAAG(CT)(AG)-
(CT)GTGTGCTA (the 3 CTA is the termination codon).
To construct the S. galili Clock cDNA with a replaced human
Q-rich (glutamine-rich) domain (sClock-hQ) and the human
equivalent (hClock-sQ), Clock cDNA fragments from both
species, equivalent to Spalax amino acids numbers 1–744 and
736–865 (see GenBank accession no. AJ318057) were amplified
and joined by PCR.
Spalax MOP3 cDNA was also cloned by RT-PCR from S. galili
brain tissue by using oligonucleotides designed according to the
published sequence of human MOP3 (GenBank accession no.
AF044288) and that of the mouse (GenBank accession no.
AB015203). These were a 5 sense oligonucleotide 5-TG(TC)(G
A)A(CG)(TC)(TA)C(AC)G(AT)(TC)C(AT)TCCAATG
(the 3 ATG is the initiation codon) and a 3 antisense oligonu-
cleotide 5GCCAAAGCAACATGTAGTGT(TC)(TC)A. The
(TC)(TC)A is a combination of the three possible termination
codons. The tissues used in this study for the RT-PCR experiments
were collected at the same time from all individuals.
Similarity Tree. The tree presented is a protein (amino acids)-
based tree using Kimura’s protein distance (29). The tree is
derived by using the Wisconsin package version 10 (Genetics
Computer Group, Madison, WI), using the neighbor-joining
method. We chose this method after Weir (30), who summarized
the simulation studies and showed that this method is among the
best methods based on distance matrices.
Transcriptional Activity. The entire ORFs of Spalax (s) and human
(h) Clock as well as sClock-hQ and hClock-sQ were cloned into
the pTARGET expression vector (Promega). Plasmids express-
ing these constructs were cotransfected with an hMOP3 or
sMOP3-expressing plasmid and the M34RE-luciferase reporter
plasmid into the human hepatoma cell line Hep3b. The M34RE-
luciferase has three E-box elements (the CACGTG sequence),
a transcription factor-binding site found in the Per1 promoter
region, in tandem upstream of the luciferase gene (25). Trans-
fections were performed by means of Lipofectamine (Life
Technologies). In all experiments, the luciferase reporter activity
was normalized to -galactosidase expression resulting from
cotransfection of a control plasmid [a cytomegalovirus (CMV)
promoter that drives the expression of the -galactosidase gene].
Cells were incubated for 20 h before harvest. The luciferase
activity was determined as described (25). The relative light units
(RLUs) were calculated from the luciferase activity divided by
the -galactosidase activity for each assay.
In Situ Hybridization. Animals used for testing the brains were kept
in a controlled environment of 12-h light12-h dark. All specimens
came from diurnal animals, as was proven by monitoring their
locomotor activity. Spalax brains were removed under sterile con-
ditions at Zeitgeber times ZT0, ZT6, ZT12, and ZT18 (ZT0 is when
lights are turned on, and ZT12 is when lights are turned off) and
fixed in ice-cold 4% paraformaldehydePBS for 16–20 h. Tissues
were dehydrated, embedded in paraffin, and sectioned at a thick-
ness of 10 m. In situ hybridization was performed as described
(31). The Clock probes corresponded to nucleotides 423-1290 of
Spalax cDNA (amino acids 141–430 in accession no. AJ318057) and
the MOP3 probes to nucleotides 1–864 of Spalax cDNA (amino
acids 1–288 in accession no. AJ318060). Antisense and sense
riboprobes were synthesized with T3 or T7 RNA polymerase in the
presence of 5-35S-UTP (1,250 Ci/mmol; 1 Ci 37 GBq; DuPont
NEN). Hybridization was done overnight at 55°C. Stringency
washes were performed at 64°C. Slides were dipped in NTP-2
emulsion and exposed for 6 days. Tissue was visualized by fluores-
cence of Hoechst dye 33258-stained nuclei (blue color in figure).
Silver grains were visualized by dark-field illumination. Image is a
videograph captured with ADOBE PHOTOSHOP. Experiments were
performed in duplicate.
Results
Spalax Clock and MOP3 cDNA Structure. A full length Spalax cDNA
for Clock was isolated from three of the Israeli species, namely
S. galili, S. carmeli, and S. judaei. A full-length cDNA of Spalax
MOP3 was isolated from S. galili. The clones were obtained by
RT-PCR of brain tissue by using oligonucleotides from the
translational initiation and termination sites of the previously
published human and mouse counterparts.
The Spalax Clock cDNA is over 90% similar to the genes of
mice, rats (accession no. NM021856), and humans (for the
complete cDNA sequences and the deduced amino acids of the
three Spalax species see accession nos. AJ318057, AJ318058, and
AJ318059). Translated, however, Spalax Clock cDNA encodes a
protein of 865 aa compared with 855 in mice, 846 in humans, and
862 in rats (32). The Gly-Met-Asn-Thr at positions 610–613 in
human, missing in mouse, occur in the three Spalax species,
though Thr is replaced by Ala in all Spalax species. Glutamine
at position 629 in mice is missing in humans, and occurs in all
Spalax species. Table 1 summarizes the synonymous and non-
synonymous mutations among the three Spalax species studied
and then between them and humans and mice. Spalax has 18–26
amino acid substitutions compared with humans, and 35–42
substitutions compared with mice. S. judaei (S60) and S. carmeli
(S58), geographically adjacent species, differ in 8 amino acids
and 12 mutations. S. judaei differs from the more northern
species, S. galili (S52), in 10 amino acids and in a total of 13
mutations. S. galili and S. carmeli, which are geographical
neighbors, differ in 3 amino acids and 7 mutations. The bHLH
domain and the two PAS domains of Clock cDNA are similar in
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all studied species. The most impressive difference between
Spalax and humans and mice is in the Q-rich domain as can be
seen in Fig. 1. The Spalax repeat is 18 aa longer than that found
in humans and 5 aa longer than that of mice and it is different
in amino acid composition from rats.
The S. galili MOP3 cDNA (accession no. AJ318060) is also
very similar to those of mouse and human. The putative peptide
encodes 626 amino acids. Like human MOP3 (accession no.
AF044288), it misses the Leu-Asp-Asp-Phe-Ala-Phe-Glu, which
appears in the mouse (position 48 to 54 in the mouse peptide,
accession no. AB015203). There are 8 unique amino acid
substitutions in the Spalax peptide (positions 304, 306, 330, 332,
334, 338, 476, and 580). However, the activity domains bHLH
and PAS are completely identical in the three species.
The Clock Similarity Trees. We have used the Kimura distances (30)
to generate two trees. One is based on the distances between nucleic
acids and the other is based on distances between amino acids (Fig.
2). The method examines each pair of aligned sequences item by
item and counts the number of exact matches, partial matches, and
gap symbols. If the sequences are nucleic acids, transitions and
transversions are also tallied. The Clock similarity trees show that
S. judaei, the youngest species, seems to evolve faster than its older
sibling species. Furthermore, Spalax is somewhat closer to humans
than to mice in CLOCK protein structure (see also Table 1). This
result is in contrast with all other phylogenetic trees of Spalax
derived from other sets of data (6–8).
Function of the ClockMOP3 Dimer. As already stated above, Spalax
has a distinctly different polyglutamine (polyQ) repeat (Fig. 1). The
Spalax MOP3 is very similar to the human MOP3 repeat, but also
to the mouse protein. To functionally test whether the difference in
the Q-repeat affects Spalax Clock activity, we compared S. galili
Clock with human Clock, which is shorter by 18 aa at the polyQ
domain. This was done by an assay that measures transactivation by
ClockMOP3 heterodimer of E-box elements, a type of transcrip-
tion factor-binding site found adjacent to Per1 and important for
Per1 expression (25). We found that Spalax Clock is a bona fide
partner of MOP3 as shown by this E-boxluciferase reporter assay.
Note too that its activity is only 30%, hence, it is significantly lower
(P  0.001) compared with human protein (Fig. 3). Dimerizing
human or Spalax Clock with human or Spalax MOP3 does not
influence their relative activity. However, replacing the Q-rich
domain between the two species does invert their relative activity.
That is to say, that hClock-sQ as a dimer of either hMOP3 or
sMOP3 is as active as sClock, and sClock-hQ as a dimer of either
hMOP3 or sMOP3 is as active as hClock (Fig. 3).
The Expression of Spalax Clock and MOP3. In situ hybridization
localizes Spalax Clock and MOP3 expression to the SCN in the brain
(Fig. 4), the center of the mammalian circadian clock (5). Spalax
Clock does not oscillate, but its MOP3 does oscillate, which is similar
to what is found in other species studied (23). Furthermore,
RT-PCR demonstrates (Fig. 5) that Spalax Clock is expressed in
several different organs, i.e., in the brain, retina, and harderian
gland, as well as in the peripheral tissues kidney and liver. MOP3 is
expressed in all tissues studied. Its expression is quite low in kidney
and spleen; however, like Clock, it is expressed in those tissues that
Table 1. Summary of mutations in Clock cDNA
S52 S58 S60 Mus Hu
S52 —
S58 3ns  4s (7) —
S60 10ns  3s (13) 8ns  4s (12) —
Mus 37ns  148s (185) 35ns  150s (185) 42ns  151s (193) —
Hu 18ns  154s (172) 26ns  147s (173) 26ns  152s (178) 25ns  193s (218) —
The distances in Clock cDNA sequence among the three Spalax species studied (S52, S58, and S60), mouse (Mus),
and humans (Hu). The distance is expressed in number of synonymous (s) and nonsynonymous (ns) substitutions.
The total number of substitutions appears in parentheses. Note the larger number of substitutions between
Spalax and humans than that between Spalax and mouse. Also noteworthy is the unusual larger number of
nonsynonymous mutations compared with the synonymous substitutions among the Spalax species, indicating
interspecies functional changes.
Fig. 1. The Q-rich domain of Spalax Clock compared with human, rat, and
mouse Clock. Spalax Clock was cloned from brain tissues of three species,
Spalax galili (2n 52), S. carmeli (2n 58), and S. judaei (2n 60) by RT-PCR,
with oligonucleotides from the published sequence of mice, rats, and humans
as specified in the text. Two independent clones on both strands confirmed
each sequence. The figure depicts a Prettybox of the Clock Q-rich domain of
the three Spalax species (S52, S58, and S60), humans (H), mice (M), and rats (R).
Numbers at both sides represent the amino acids aligned. The figure displaces
multiple-sequence alignment in postscript format; shading represents regions
that agree with a calculated consensus sequence (Wisconsin package version
10). , amino acids not similar among the compared species.
Fig. 2. Similarity tree of the Clock protein. The unrooted tree describes the
similarity relationships among the Clock of the three Spalax species (S52, S58,
and S60), mice (Mus), rats (Rattus), and humans (Homo). The calculated
distances show a somewhat closer relationship of Spalax Clock to human than
to mouse Clock and a faster evolution of the younger S. judaei (2n 60) than
its older sibling species S. galili (2n  52) and S. carmeli (2n  58).







are involved in the maintenance of the circadian system, namely
brain, eye, and harderian gland. As demonstrated in Fig. 6, MOP3
also oscillates in the harderian gland, and although its oscillatory
pattern is different from its pattern in the SCN, the peak of its
expression is identical in both tissues.
Discussion
Circadian rhythm is localized in the central nervous system and is
entrained by light signals in the eye. Lightless habitats lead to
structural regressive eye evolution (8). Is function also lost? Main-
tenance of eye rudiments after millions of years in darkness suggests
functionality. Blind subterranean mole rats, S. ehrenbergi superspe-
cies (Spalacidae, Rodentia) in Israel, have undergone evolutionary
tinkering that has optimized molecular and structural reductions
and expansions presumably through loss-and-gain of homeotic
mutations in organizing a photoperiodic system, adapting to life in
total darkness underground (8). In our current work we present
data on the cloning, structure, and expression of circadian genes
from a visually blind, subterranean mammal.
Spalax Clock and MOP3 Structure. Despite being a rodent, Spalax, an
old rodent offshoot (7, 8), is somewhat closer to humans than to
mice in Clock structure, as was already manifested for some other
genes, i.e., Mhc loci (33), VEGF cDNA (34), and HMG1 genes
(preliminary results). Spalax presumably still retains early rodent
patterns reorganized and adapted to life underground. Spalax Clock
demonstrates distinct interspecies polymorphism and S. judaei, the
youngest species of the Spalax ehrenbergi superspecies in Israel (6,
7), seems to evolve faster than the relatively older S. galili and S.
carmeli species, suggesting distinct interspecies divergence across
very short geographic distance (80 km). This may be due to its
unique xeric ecology with large territories and its polyphasic activity
pattern in a stressful climate (6–8). Note that already in our first
study of activity patterns of different S. ehrenbergi species (20), we
found that S. judaei, which inhabits a significantly warmer and drier
environment than the northern species, S. galili and S. carmeli, has
a significantly different activity profile in both levels and patterns.
S. judaei is less active and has more, albeit shorter, periods of
activity, displaying an adaptive strategy of increasing fitness in xeric
environments (20).
Evolution of the Clock Gene in Spalax Species. The phylogenetic
relationship of the four Spalax species was analyzed earlier by
allozymes (35), mtDNA (36, 37), and DNA–DNA hybridization
(38). The tree presented here displaying the interspecies Clock
similarity relationship of the three Spalax species is different from
the phylogenetic trees derived from allozymes, mtDNA, and DNA–
DNA hybridization. Like the tree derived from cytochrome b (39),
the Clock tree seems to represent not chronological relationships,
but a gene tree that describes the rate of ecological evolution of the
Clock gene in different species. This assumption is supported by the
comparison between silent and nonsilent substitutions presented in
Table 1. This table shows that the distances with human and mouse
Clock involves 3 to 7 times more silent substitutions than nonsilent
Fig. 3. A comparison of the transcriptional activities of Spalax (s) and human (h)
ClockMOP3 dimer. Human hepatoma Hep3b cells were cotransfected with 1g
of each plasmid expressing the sClock or hClock, sClock-hQ or hClock-sQ, hMOP3
or sMOP3, and the different dimers as specified under the x axis of the graph. The
M34RE-driven luciferase reporter plasmid (0.2 g) was also transfected, along
with 0.1 g of the -galactosidase control plasmid. The luciferase and -galac-
tosidase activities were measured as described in the text. Relative light units
(RLU) were defined as the activity of luciferase divided by that of-galactosidase
(y axis). The data represent the mean SE of triplicate samples. The difference in
activity between the hClock or sClock-hQ with either sMOP3 or hMOP3 and the
other combinations is highly significant (P 0.001).
Fig. 4. In situ hybridization of Clock and MOP3 in the SCN of Spalax. S. judaei
(2n  60) were killed, and brains were treated as described in Materials and
Methods. ZT, Zeitgeber time (h). The red grains depict the Clock-hybridization
areas and the yellow grains depict the MOP3-hybridization areas. The control
panel (Bottom Right) is a negative control carried out with identical, but sense,
riboprobes. Notice that, contradictory to Clock, MOP3 is oscillating as can be seen
in the intensity of the colored grains. (Bar  ZT) The graph (Bottom Left) is a
quantified representation of the in situ hybridization. Values are densitometric
data done with NIH IMAGE. Maxima are 100% for each gene. Error bars are SD.
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mutations, which is the usual result when comparing sequences.
However, a comparison of the three Spalax species exhibits 2 to 3
times more substitutions that cause amino acid changes than those
that are synonymous. This is a very unusual observation in phylo-
genetic trees. The dramatic divergence of the youngest species, S.
judaei, which displays much faster evolution (more amino acid
changes) cannot be reconciled with its relatively recent divergence
(6–8, 40). It appears more plausible that ecological factors were
involved, such as spatiotemporal increasing stressful aridity, which
may indirectly affect the circadian pattern, as was demonstrated by
radiotracking in time.§
Expression and Function of the ClockMOP3 Dimer. Circadian oscil-
lators appear to be highly conserved throughout evolution and
involve transcription-translation negative feedback loops (3, 23).
The observation that PAS proteins play an important role in
maintaining circadian rhythms supports this idea (41, 42). A
distinguishing characteristic of the Clock gene is the presence of
several functional domains in its amino acid sequence. These are the
bHLH (amino acids 34–81), the PAS A direct repeat (amino acids
115–163), the PAS B direct repeat (amino acids 272–318), and the
Q-rich domain at the C terminus. Although the bHLH and PAS
domains are very conserved among the different Clock cDNAs that
have been cloned, the most striking difference is in the significant
variation in the Q-repeat near the C terminus of Clock. The
Q-repeat characterizes the activation domains of many transcrip-
tion factors (43), and it has been shown to influence circadian
rhythmicity (44). It has been shown that A 3 T nucleotide
transversion in a splice donor site, which results in exon skipping
and a deletion of 51 aa from the Q-repeat area in the mouse protein,
appears to be the cause of a number of changes in the circadian
phenotype (45). Most notably, mice homozygous for this deletion
manifest a 3–4 h longer period (27–28 h) on initial placement in the
dark and then become arrhythmic after a few weeks in darkness. A
6-h exposure to light of these arrhythmic mice restores the long-
period rhythmicity. Hence, in addition to a bHLH region (DNA
binding domain) and PAS region (protein dimerization domain)
Clock also contains a transcriptional activation domain (the Q-rich
region). The mutant protein can therefore compete with nonmu-
tant Clock for binding partners andor DNA binding sites, which
explains the dominant negative nature of the mutant allele (44).
Evidence demonstrates that proper activity of the circadian
system requires heterodimerization of two bHLH-PAS proteins:
Clock and MOP3 (25, 26, 46). Our results prove that there is a
reduced transcriptional activity (P  0.001) of the Spalax Clock
MOP3 dimer compared with humans, possibly increasing metabolic
economy (15). The fact that this pattern is retained after inter-
changing the Q-rich domains of the two species supports an
assumption that it is this domain that causes the difference in
transcriptional activity. It was already shown that mutant Clock
could form heterodimers with MOP3 that bound DNA but failed
to activate transcription (46). Moreover, such a mutant, probably by
down-regulating the oscillations of Pers and Crys RNA, leads to
reduced levels of MOP3 transcription, hence limiting the available
ClockMOP3 heterodimers at the appropriate circadian time to
drive PerCry transcription and restart the cycle (27). This suggests
that Clock, after binding to a specific transcription activation site
(the E-box), upstream the initiation site of Per, appears to drive the
positive component of Per transcriptional oscillations, which are
thought to underlie circadian rhythmicity. Thus, the Spalax-unique
Clock may partially inactivate transcription, while retaining the
ability to bind DNA and dimerize with partners. Further studies are
essential to directly relate the unique polyQ repeat of Spalax Clock,
with the reduced transactivation by Spalax Clock or with its unique
polytypic (20), polymorphic (19), and seasonal§ differences in
circadian rhythms. Nevertheless, other differences in the Spalax
Clock or MOP3 sequence, although evolutionarily impressive, can-
not be related to any presently known functional sites. Hence, the
reduced activity of Spalax Clock may be cautiously attributed to the
different polyQ of its protein. Transgenic mice with Spalax Clock
may elucidate its direct function.
Tissue Distribution and Oscillation of Spalax Clock and MOP3 Expres-
sion. As in other mammals, Spalax Clock does not oscillate, but
Spalax MOP3 does oscillate (23). Notably, the oscillatory pattern of
MOP3 in the Spalax SCN is a mirror image of that of the mouse Per1
(32) as well as the Spalax equivalent (preliminary results). That is,
MOP3 expression is at its minimum at ZT6, when Per1 expression
is at its maximum. This observation may be explained by Shear-
man’s et al. (27) interpretation of the feedback mechanism between
ClockMOP3 heterodimer level and the transcription drive of
PerCry.
The tissue distribution of Spalax Clock is not restricted to tissues
directly related to the maintenance of the biological clock, as was
reported in mice (44). It may be involved, as was shown in
Drosophila, in both circadian (47) and noncircadian oscillations in
nonpacemaker tissues (48), or as hypothesized by Yamazaki et al.
(49) in transgenic rats, that a self-sustained circadian pacemaker in
the SCN entrains circadian oscillations in the peripheral tissues.
MOP3 is expressed in all tissues studied, which is similar to what was
demonstrated in mice and may reflect its involvement as an orphan
dimerizing protein in other transcription activation systems, like the
hypoxia-inducible factor (25).
Fig. 5. Tissue distribution of Clock and MOP3 expression in Spalax. The distri-
bution of Clock (Ck) and MOP3 expression was characterized by RT-PCR of a
fragment of each cDNA, on total RNA samples prepared from the following S.
galili tissues: kidney (lane 1); intestine (lane 2); liver (lane 3); heart (lane 4); spleen
(lane 5); brain (lane 6); muscle (lane 7); testis (lane 8); lung (lane 9); harderian
gland (lane 10); and eye (lane 11). The Clock gene (Top, Ck) is expressed in brain
tissue, retina, and harderian gland, as well as in peripheral tissues: kidney and
liver. MOP3 (Middle, MOP3) is expressed in all tissues examined, although its
relative expression in the kidney (lane 1) and spleen (lane 5) is low. An internal
380-bpfragmentofactincDNA(Bottom,Ac)wasamplifiedbyRT-PCR in thesame
reactiontubesasClockorMOP3,withactin-specificprimersasan internal control.
Fig. 6. Expression of MOP3 and Clock in the harderian gland of Spalax. S. galili
(2n 52) kept in a 12-h light12-h dark cycle were killed at different Zeitgeber
time points. Harderian glands were treated as described in Materials and Meth-
ods. The graph is a quantified representation of the in situ hybridization. Values
are the densitometric data done with NIH IMAGE. Maxima are 100% for each gene.
Notice that contradictory to Clock, MOP3 is oscillating. Bars are SD.







Clock and MOP3 Expression in the Harderian Gland. We are aware of
no other report of expression of circadian genes in the harderian
gland. Although the oscillatory pattern of MOP3 is different from
its pattern in the SCN, the peak of its expression is identical in both
tissues. This may indicate a unique synchronization of these two
tissues that has yet to be clarified, because in other tissues there is
always a lag in the peak of expression of oscillatory circadian genes
between the SCN and peripheral tissues. The expression of Clock
and MOP3 in the harderian gland of Spalax is remarkable and
should be emphasized: the harderian gland of Spalax is tremen-
dously hypertrophied, occupying the entire eye-socket, whereas the
eye is degenerated (0.7 mm in diameter), subcutaneous, and
embedded in that huge harderian gland. It was previously suggested
that the harderian gland of Spalax is a possible photoreceptor and
photoperiodic organ (11).
Circadian Genes in a Blind Subterranean Mammal. Expression of
circadian genes in blind Spalax may highlight the genetic basis of its
behavioral pattern of circadian rhythmicity (19–22). We have
already cloned the Spalax cDNA homologs of Per1, Per2, Per3, Tim,
Cry1, and Cry2 (unpublished results). We plan to evaluate their
function and their potential convergence in other subterranean
mammals. Likewise, the Spalax photoreceptor pigment rhodopsin
(16) and long-wavelength coneopsin (17, 18, 50) have been cloned
and sequenced, and their unique Spalax function in photoentrain-
ment was evaluated, presumably as adaptations to life underground
by significant enrichment for wavelengths greater than 500 nm,
maximizing photon capture, but minimizing the effects of heat (18).
The mosaic evolution of the Spalax eye (7, 14, 15), harderian
gland (51), and brain (52), and its circadian genes provides a
dramatic model of tinkering evolution at both the molecular and
organismal levels. From an evolutionary perspective, the genetic
basis of circadian rhythms in blind subterranean mole rats may
be different from that of strictly diurnal or nocturnal and sighted
mammals. The identification of the blind Spalax Clock might
help, together with its other circadian genes, highlighting the
structure and evolution of the circadian organization in mam-
mals, including humans, at the molecular level and their eco-
logical causation. Furthermore, it may highlight both adaptive
evolution linking structure and function and behavioral–
molecular interactions of regression, progression, and conver-
gence in subterranean mammals generally, and especially in the
Pleistocene ecological speciation of the Spalax ehrenbergi super-
species caused by increasing ecological aridity stresses (6–8),
which in turn affect the patterns of circadian rhythmicity. It
could also elucidate, by transgenic studies in mice, the control of
the Spalax-unique polyphasic, polymorphic, and seasonal cycles,
as well as sleeping disorders, work shifts, and jetlag in humans.
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